Rat cell line derived from liver lacking growth hormone.
Comment from the depositor
Terms and conditions
1) As a rule, it make joint researches and required written permission from the approver. 2) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Hum Cell 2010;23:164-172) designated by the DEPOSITOR is required. 3) Before apply for a patent, contact a person who establish a cell line.
Remarks
approver's address
×
English
Address
Nippon Medical School, Musashi Kosugi Hospital Department of Endocrinology, Diabetes and Arteriosclerosis 1-396 Kosugi-machi, Nakahara-ku, Kawasaki-shi, Kanagawa 211-8533 Japan
Dr.ISHIKAWA Mayumi
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
3641
Ishikawa M, Tachibana T, Yoshino G, Hashimoto H, Tanaka T.
Novel functional hepatocyte cell line derived from spontaneous dwarf rat: model of growth hormone function in vitro.Hum Cell
2010
23(4):164-72
PubMed ID: 21166888
DOI: 10.1111/j.1749-0774.2010.00097.x